Abate Eye Hospital introduces Kerala's First Alcon Vision Suite

Abate AS Industries Ltd, through its healthcare subsidiary Abate Eye Hospital, a business division of Prudential Management Services Limited, has announced the launch of the Alcon Vision Suite (AVS), an advanced, fully integrated digital ecosystem for ophthalmic care, marking its first-ever installation in Kerala.

This milestone positions Abate Eye Hospital at the forefront of cutting-edge eye care technology in the region, reinforcing its commitment to delivering world-class, ethical, patient-centric healthcare solutions.

The AVS is designed to seamlessly connect and synchronise every stage of the ophthalmic surgical journey, from diagnostics and surgical planning to operating room visualisation and postoperative care. By integrating advanced platforms, AVS enhances precision, efficiency, and overall patient outcomes. A key highlight of the system is the NGENUITY® 1.5 3D Visualization System, which offers superior clarity, enhanced depth perception, and improved ergonomics for surgeons, complemented by the ADi digital surgical planning platform that enables highly precise and personalized preoperative planning.

The AVS, marking its first installation in Kerala, sets a new benchmark in ophthalmic innovation with advanced 3D visualization for enhanced surgical accuracy, personalized digital surgical planning, reduced variability and improved refractive outcomes, greater operating room efficiency, more predictable and tailored patient results, and enhanced training capabilities for young ophthalmologists.

Speaking on the development, Mr. Arikuzhiyan Samsudeen, Chairman and Non-Executive Director, said: "Healthcare is entering a new era where precision, predictability, and patient experience are driven by technology. With the introduction of Kerala's first Alcon Vision Suite, we are redefining the entire ophthalmic care journey, from diagnosis to recovery. This investment reflects our commitment to bringing world-class, technology-led eye care to our patients while also empowering the next generation of ophthalmologists."

The introduction of AVS represents a significant technological leap for the region, enabling more accurate, efficient, and patient-focused care in cataract and glaucoma surgeries. It also strengthens Abate Eye Hospital's role as a center of excellence in ophthalmology, supporting both patient care and medical training.

This initiative is a strategic step in advancing Abate's long-term vision of delivering world-class, technology-driven, and ethical eye care. By integrating cutting-edge solutions like the AVS, the organization aims to enhance clinical precision, improve patient outcomes, and set new benchmarks in ophthalmology.

It also reinforces Abate's commitment to continuous innovation, capacity building, and bringing globally recognized standards of care to India, particularly in emerging healthcare markets.

Shares of Abate AS Industries LTD. was last trading in BSE at Rs. 10.87 as compared to the previous close of Rs. 11.42. The total number of shares traded during the day was 44795 in over 131 trades.

The stock hit an intraday high of Rs. 11.98 and intraday low of 10.85. The net turnover during the day was Rs. 492103.00.

Source : Equity Bulls

Keywords

ABATEASINDUSTRIES INE454E01013 AbateEyeHospital AlconVisionSuite Kerala